Organogenesis Holdings Inc. (ORGO) 当前追踪市盈率 (P/E) 为 7.8, 前瞻市盈率为 8.7. 追踪盈利收益率为 12.85%, 前瞻盈利收益率 11.56%. PEG 0.09 (Peter Lynch 低估标准 ≤1.0). 格雷厄姆数为 $4.74.
本页证实的标准:
SharesGrow 综合评分： 82/100 其中 5/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | -400.8 | 0.00 | 0.28 | 0.00 | - |
| 2017 | -302.6 | -8.65 | 2.13 | 0.00 | - |
| 2018 | -10.8 | 0.00 | 14.88 | 3.62 | - |
| 2019 | -11.5 | 0.22 | 8.03 | 1.71 | - |
| 2020 | 47.1 | -0.35 | 5.72 | 2.40 | - |
| 2021 | 12.6 | 0.04 | 4.91 | 2.54 | - |
| 2022 | 22.5 | -0.27 | 1.32 | 0.78 | - |
| 2023 | 108.5 | -1.58 | 1.93 | 1.24 | - |
| 2024 | 489.4 | -4.12 | 1.09 | 0.87 | 0.43% |
| 2025 | 17.7 | -0.01 | 1.51 | 1.16 | 1.73% |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $0.00 | $0.00 | $-208.7K | - |
| 2017 | $-0.03 | $0.00 | $-2.09M | - |
| 2018 | $-0.94 | $193.45M | $-64.83M | -33.5% |
| 2019 | $-0.44 | $260.98M | $-40.45M | -15.5% |
| 2020 | $0.15 | $338.3M | $17.23M | 5.1% |
| 2021 | $0.70 | $468.06M | $94.2M | 20.1% |
| 2022 | $0.12 | $450.89M | $15.53M | 3.4% |
| 2023 | $0.04 | $433.14M | $4.95M | 1.1% |
| 2024 | $-0.01 | $482.04M | $861K | 0.2% |
| 2025 | $0.15 | $564.17M | $37.03M | 6.6% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $-0.17 | $-0.17 – $-0.17 | $401.22M | $401.22M – $401.22M | 1 |
| 2027 | $0.29 | $0.29 – $0.29 | $506.59M | $506.59M – $506.59M | 1 |
